Supplementary Tables from Phase I–II Open-Label Multicenter Study of Palbociclib + Vemurafenib in BRAFV600MUT Metastatic Melanoma Patients: Uncovering CHEK2 as a Major Response Mechanism
收藏aacr.figshare.com2023-06-07 更新2025-03-22 收录
下载链接：
https://aacr.figshare.com/articles/dataset/Supplementary_Tables_from_Phase_I_II_Open-Label_Multicenter_Study_of_Palbociclib_Vemurafenib_in_i_BRAF_i_sup_V600MUT_sup_Metastatic_Melanoma_Patients_Uncovering_CHEK2_as_a_Major_Response_Mechanism/22480542/1
下载链接
链接失效反馈官方服务：
资源简介：
Tables S1, S2, S3, S4
表格 S1, S2, S3, S4
提供机构：
American Association for Cancer Research
